Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 27;56(9):e00686-18.
doi: 10.1128/JCM.00686-18. Print 2018 Sep.

Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations

Affiliations

Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations

Kamela C S Ng et al. J Clin Microbiol. .
No abstract available

Keywords: Ultra probes; Xpert MTB/RIF Ultra; disputed mutations; melt peak temperature (Tm); melting temperature shift (ΔTm); rifampin-resistant tuberculosis; rpoB mutations.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Overview of Xpert Ultra test results. The observed probe reactions for each RRDR mutation were laid over the claimed probe coverage (light gray). Shown in black are probe reactions concordant with manufacturer claims, in blue are probe reactions missed by one probe but captured by another probe, and in red is a probe reaction representing a “RIF Resistance Indeterminate” result from 3 out of 4 strains tested. Results in the hatched pattern were superimposed for greater visibility.
FIG 2
FIG 2
Melting temperature shifts (ΔTms) observed upon detection of a rifampin resistance (RR)-conferring rpoB mutation in the RR-determining region (RRDR) by Xpert Ultra. The y axis reflects the melting temperature difference (ΔTm) between mutant and wild-type probe-amplicon hybrids, while the x axis shows the mutations that we tested. The data points on the graph are ΔTm values grouped by their associated Ultra probes (differentiated by color), which correspond to a specific rpoB mutation. x axis labels in brown are disputed mutations.

References

    1. Andre E, Isaacs C, Affolabi D, Alagna R, Brockmann D, de Jong BC, Cambau E, Churchyard G, Cohen T, Delmee M, Delvenne JC, Farhat M, Habib A, Holme P, Keshavjee S, Khan A, Lightfoot P, Moore D, Moreno Y, Mundade Y, Pai M, Patel S, Nyaruhirira AU, Rocha LE, Takle J, Trebucq A, Creswell J, Boehme C. 2016. Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination. Int J Tuberc Lung Dis 20:999–1003. doi:10.5588/ijtld.16.0015. - DOI - PMC - PubMed
    1. Ng KC, Meehan CJ, Torrea G, Goeminne L, Diels M, Rigouts L, de Jong BC, Andre E. 2018. Potential application of digitally linked tuberculosis diagnostics for real-time surveillance of drug-resistant tuberculosis transmission: validation and analysis of test results. JMIR Med Inform 6:e12. doi:10.2196/medinform.9309. - DOI - PMC - PubMed
    1. Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D. 2017. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio 8:e00812-17. doi:10.1128/mBio.00812-17. - DOI - PMC - PubMed
    1. van Deun A, Aung KJ, Bola V, Lebeke R, Hossain MA, de Rijk WB, Rigouts L, Gumusboga A, Torrea G, de Jong BC. 2013. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol 51:2633–2640. doi:10.1128/JCM.00553-13. - DOI - PMC - PubMed
    1. Rosser A, Marx FM, Pareek M. 2018. Recurrent tuberculosis in the pre-elimination era. Int J Tuberc Lung Dis 22:139–150. doi:10.5588/ijtld.17.0590. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources